Dabigatran: is there a role for coagulation assays in guiding therapy?
about
A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin timeEnhanced elimination of dabigatran through extracorporeal methods.Evaluation of the chromogenic anti-factor IIa assay to assess dabigatran exposure in geriatric patients with atrial fibrillation in an outpatient setting.A Review of and Recommendations for the Management of Patients With Life-Threatening Dabigatran-Associated Hemorrhage: A Single-Center University Hospital Experience.Idarucizumab for Reversal of Dabigatran-Associated Anticoagulation.Determination of dabigatran in plasma, serum, and urine samples: comparison of six methods.
P2860
Dabigatran: is there a role for coagulation assays in guiding therapy?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Dabigatran: is there a role for coagulation assays in guiding therapy?
@en
type
label
Dabigatran: is there a role for coagulation assays in guiding therapy?
@en
prefLabel
Dabigatran: is there a role for coagulation assays in guiding therapy?
@en
P2860
P356
P1476
Dabigatran: is there a role for coagulation assays in guiding therapy?
@en
P2093
Farooq Bandali
P2860
P304
P356
10.1345/APH.1R720
P407
P577
2013-05-14T00:00:00Z